Inventor

THURSTON GAVIN

US77 patents

⚠️ This page may combine multiple inventors who share the name “THURSTON GAVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THURSTON GAVIN

REGENERON PHARMA

Human antibodies to PD-1

Anti-EGFR antibodies and uses thereof

Anti-PRLR antibodies and methods for killing PRLR-expressing cells

Anti-LAG3 antibodies and uses thereof

Human antibodies to human delta like ligand 4

Human antibodies to human delta like ligand 4

Human antibodies to PD-L1

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

Angiopoietins and methods of use thereof

Anti-CD8 antibodies and uses thereof

Anti-EGFRvIII antibodies and uses thereof

Methods for treating cancer by administering an anti-Ang-2 antibody

Human antibodies to human delta like ligand 4

Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

Methods and antibody compositions for tumor treatment

Methods and compositions comprising a combination of a VEGF Trap and an anti-CTLA-4 antibody

Anti-Tie2 antibodies and uses thereof

Anti-PRLR antibodies and methods for killing PRLR-expressing cells

Anti-CD8 antibodies and uses thereof

Multispecific antigen-binding molecules and uses thereof

Method of treating cancer with DLL4 antagonist and chemotherapeutic agent

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

Methods and antibody compositions for tumor treatment

Anti-EGFRvIII antibodies and uses thereof

Human antibodies to PD-1

Anti-TIE2 antibodies and uses thereof

Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat cancer

Anti-LAG3 antibodies and uses thereof

Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Method of using mouse having a humanized cluster of differentiation 47 gene

Anti-CTLA-4 antibodies and uses thereof

Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells

Methods for tumor treatment using CD3XCD20 bispecific antibody

Antagonist antibodies to human prolactin receptor (PRLR)

Markers of tumor cell response to anti-cancer therapy

Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) antibodies

Anti-CD8 antibodies and uses thereof

Multispecific antigen-binding molecules and uses thereof

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

Anti-TIE2 antibodies and uses thereof

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

Mouse having a humanized cluster of differentiation 47 gene

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

THURSTON GAVIN

High affinity human antibodies to human angiopoietin-2

Anti-Tie2 antibodies and uses thereof

NOGUERA-TROISE IRENE

Method of treating cancer with DLL4 antagonist and chemotherapeutic agent

REGENERAN PHARMACEUTICALS INC

Human antibodies to PD-L1